Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Viking Therapeutics, Inc. (VKTX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $345.0M | $101.6M | $63.8M | $54.2M | $45.0M | $31.9M | $23.6M | $19.0M | $13.7M | $9.0M | $7.0M | $22.2M |
| Operating expenses | $393.3M | $150.9M | $100.8M | $70.4M | $55.7M | $42.7M | $32.7M | $26.2M | $19.1M | $13.8M | $12.0M | $23.5M |
| Operating income | −$393.3M | −$150.9M | −$100.8M | −$70.4M | −$55.7M | −$42.7M | −$32.7M | −$26.2M | −$19.1M | −$13.8M | −$12.0M | −$23.5M |
| Net income | −$359.6M | −$110.0M | −$85.9M | −$68.9M | −$55.0M | −$39.5M | −$25.8M | −$22.1M | −$20.6M | −$14.7M | −$23.4M | −$21.9M |
| Basic EPSper diluted share | -$3.19 | -$1.01 | -$0.91 | -$0.90 | -$0.71 | -$0.54 | -$0.36 | -$0.38 | -$0.79 | -$0.90 | -$3.68 | -$5.23 |
| Diluted EPSper diluted share | -$3.19 | -$1.01 | -$0.91 | -$0.90 | -$0.71 | -$0.54 | -$0.36 | -$0.38 | -$0.79 | -$0.90 | -$3.68 | -$5.23 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 10, 2026Form 4 | Aubuchon Neil WilliamChief Commercial Officer | BuyCommon Stock, par value $0.00001 per share | 4.5K | $33.50 | $149.9K | 4.5K |
| Jan 5, 2026Form 4 | ZANTE GREGChief Financial Officer | SellCommon Stock, par value $0.00001 per share | 1.5K | $32.09 | $48.1K | 189.9K |
| Jan 5, 2026Form 4 | ZANTE GREGChief Financial Officer | SellCommon Stock, par value $0.00001 per share | 10.3K | $34.24 | $352.7K | 191.4K |
| Jan 5, 2026Form 4 | ZANTE GREGChief Financial Officer | SellCommon Stock, par value $0.00001 per share | 13.9K | $33.38 | $464.0K | 201.7K |
| Jan 5, 2026Form 4 | ZANTE GREGChief Financial Officer | SellCommon Stock, par value $0.00001 per share | 32.0K | $32.30 | $1.03M | 215.6K |